Abstract
Candida albicans is a benign member of gut microbiota, but also causes life-threatening disseminated infections, suggesting that this fungus commensalism has evolved with retention of virulence traits. Here we reveal that N-acetylglucosamine (GlcNAc) enables C. albicans to balance between commensalism and pathogenesis. Although GlcNAc catabolism is beneficial for commensal growth of C. albicans, deleting GlcNAc sensor-transducer Ngs1 confers enhanced fitness, indicating that GlcNAc signaling is detrimental to commensalism. Interestingly, addition of GlcNAc attenuates commensal fitness of gut-evolved C. albicans but retains its disease-causing potential. We further demonstrate that GlcNAc is a major inducer of hypha-associated transcription in the gut, which represents the key determinant for commensal-pathogenic equilibrium. In addition to yeast-to-hypha morphogenesis, we also identify other factors, including Sod5 and Ofi1, that contribute to the balance. Thus, C. albicans uses GlcNAc to build up a tradeoff between fungal programs supporting commensalism and virulence, which may explain its success as a commensal and pathogen.
Similar content being viewed by others
Introduction
The yeast Candida albicans is a component of the human orogastrointestinal and genital microbiota where it can exist in a commensal state without causing pathological infection. The fungus lives and coevolves in these complex environments of the human body. Nonetheless, it is the most common fungal pathogen of humans, responsible for diseases ranging from superficial infections of the skin and mucous membranes to highly morbid, invasive infections of internal organs1,2,3, which suggests that C. albicans commensalism has evolved with retention of fungal virulence traits. Among these, the transition from yeast to hyphal cell morphology is central to C. albicans’ pathogenic potential, as strains defective in hyphal formation are attenuated in causing invasive infections in mice4,5,6. In contrast to its crucial role in pathogenicity, the hypha-associated transcription was recently shown to inhibit commensal fitness7. In this situation, fungal programs supporting commensalism and virulence seem to antagonize each other. While most studies focused on the identification of fungal factors involved in commensalism and pathogenicity7,8, little is known about the host factor(s) that determine this antagonistic relationship.
N-acetylglucosamine (GlcNAc) is a major structural component on the cell surface of a wide range of cells9. It is a component of the peptidoglycan of bacterial cell walls and the extracellular matrix glycosaminoglycans of animal cells. Because mammals digest and absorb dietary starch and oligosaccharides in the proximal small bowel, glucose is relatively depleted more distally, while gut bacteria can release GlcNAc during cell wall recycling10. GlcNAc is proposed to be a major carbon source to support the growth of C. albicans in humans11. In addition to supporting growth as an energy source, GlcNAc is a powerful inducer of morphological transitions, including hyphal development and phenotypic switching12,13, which is linked to its virulence, infection of distinct host niches and immune evasion14,15. The GlcNAc-sensor and transducer Ngs1 is the master regulator of GlcNAc signaling. It controls GlcNAc-induced expression of genes for GlcNAc catabolism, uptake, scavenging and pathogenesis16. As the focus of recent research has been on understanding how GlcNAc promotes C. albicans pathogenicity17, we know little about the exact role of this sugar on the regulation of commensalism within the healthy human host.
Here, we report that disruption of NGS1 conferred enhanced commensal fitness, which occurs independently of GlcNAc catabolism. Rather, Ngs1-mediated gene expression program including hypha-specific transcription, as well as other factors such as Ofi1, determines this hypercompetitive phenotype. By serially passaging C. albicans in gastrointestinal (GI) tract of mice, we showed that cells recovered from murine gut enriched in GlcNAc produced a commensal defect, but retained virulent attributes to some extent, compared to that recovered from the gut enriched in glucose or with no additional sugar. Thus, C. albicans has exploited GlcNAc as a GI-specific signal to balance between commensalism and virulence.
Results
Disrupting GlcNAc signaling in C. albicans confers enhanced commensal fitness
GlcNAc is an abundant carbon source supplied in the mammalian GI tract. It has been well established that GlcNAc catabolism is important for some bacteria to persist in mammalian gut18. To determine whether it is the case for the commensal-pathogenic fungus C. albicans, a competition experiment was conducted in which mice were orally inoculated with 1:1 mixtures of a nourseothricin-resistant (NATr) WT strain and an unmarked strain in which genes encoding all three GlcNAc catabolic enzymes are deleted (hxk1 dac1 nag1) (Fig. 1a, b). NAT marker was shown to have no effect on commensal fitness19. At various times postinoculation, fecal pellets were collected from mice, homogenized, and plated to determine the number of CFU per gram of sample (CFU/g) and the competitive index (CI, the ratio of the indicated strain) (Fig. 1b). As expected, hxk1 dac1 nag1 triple mutant exhibited reduced commensal fitness in competition with WT, suggesting that the ability to utilize GlcNAc as an energy source is also critical for gut commensal fitness of C. albicans (Fig. 1c). This result reinforces the opinion that GlcNAc metabolism is implicated in commensal growth of C. albicans in the GI tract10.
Ngs1 is the master regulator of GlcNAc-induced cellular programs including catabolism, scavenging, morphological transition and other processes (Fig. 1a). Consistent with its essential role for GlcNAc utilization under in vitro conditions, we detected a dramatic decrease in the expression of GlcNAc catabolic genes including HXK1, DAC1 and NAG1, as well as GIG1, another GlcNAc-inducible gene20, in ngs1 mutant compared to that in wild type during gut colonization (Fig. 1d), revealing that GlcNAc signaling must be encountered by C. albicans when it colonizes the gut. However, unlike the reduced fitness with hxk1 dac1 nag1 triple mutant during commensal growth, gig1 mutant and WT exhibit similar commensal fitness in a direct competition experiment (Fig. 1e). In addition to supporting growth as an energy source, GlcNAc often acts as a signaling molecule to induce multiple cellular programs via its sensor-transducer Ngs1 (Fig. 1a). We next asked, other than catabolism, whether GlcNAc signaling exerts influence on the fitness of C. albicans as a gut commensal. To this end, we compared the competitive fitness of WT and ngs1 mutant directly in the same animals. In contrast to our expectation, the NGS1 deletion mutant is hypercompetitive in the gut colonization model such that ngs1 mutant outcompeted WT strain at time points as early as 10 days after inoculation (Fig. 1f). At day 25, all the WT cells seemed eliminated during colonization (Fig. 1f).
WOR1, a master regulator of commensalism in C. albicans10, was shown to be upregulated in the ngs1 mutant from a global transcription profile in a GlcNAc-independent manner21. The upregulation of WOR1 in ngs1 mutant was confirmed by a qRT-PCR analysis in a murine colonization model (Supplementary Fig. 1a). To exclude the possibility that the enhanced commensal fitness of ngs1 mutant is attributed to its increased WOR1 expression, WOR1 was deleted in the ngs1 mutant. As shown in Supplementary Fig. 1b, ngs1 wor1 double mutant exhibited hypercompetitive phenotypes over wor1 single mutant, suggesting that the enhanced fitness in ngs1 mutant cannot be solely due to the higher expression level of WOR1. Instead, the inability to respond to GlcNAc signaling in the gut appears to be key determinants for the hypercompetitative phenotype of the ngs1 mutant. In support of this hypothesis, the fitness advantage of ngs1 mutant was diminished when mice were fed with 5% glucose that blocked GlcNAc signaling in the gut (Fig. 1g). Additional support for this idea comes from data of the hex1 mutant where disruption of HEX1, which encodes an N-acetylglucosaminidase responsible for external GlcNAc scavenging of C. albicans (Fig. 1a)22, conferred fitness advantage (Fig. 1h). Interestingly, hex1 mutant even outcompeted ngs1 mutant during gut colonization (Supplementary Fig. 1c). Taken together, these data suggest that GlcNAc-induced cellular programs play an inhibitory role towards C. albicans fitness when it colonizes the gut. This detrimental effect is dominant over the beneficial effect exerted by GlcNAc as energy source that promotes commensal growth.
GlcNAc reshapes the gut evolution of C. albicans
C. albicans can be experimentally induced to increase its competitive fitness in the gut of antibiotic-treated mice by means of adaptive evolution8,23. To further confirm that GlcNAc can directly inhibit C. albicans commensalism, wild-type or ngs1 mutant C. albicans cells were inoculated into mice of three groups fed with 5% GlcNAc, 5% glucose or only water respectively (Fig. 2a). For each group, this experimental evolution was performed independently in three mice (Line 1–3, Fig. 2a). After a week, the feces were transplanted from colonized to naïve mice. By four weekly serial passages, gut-evolved cells were harvested and recovered. Given that different clonal isolates from the same evolution line might display phenotype variations23, we collected all gut-evolved colonies that recovered from each mouse as a whole to represent an independent evolution line, and then subjected them for the following experiments. Recovered cells from each evolution line in GlcNAc were randomly paired with that in glucose or water, and were then orally inoculated with 1:1 mixtures to examine competitive fitness (Fig. 2a). As shown in Fig. 2b, wild-type cells recovered from mice fed with GlcNAc across all three evolution lines exhibited diminished fitness compared with cells recovered from mice fed with glucose or water. By contrast, no significant difference in commensal fitness was observed in ngs1 mutant cells in the serial fecal transplantation experiment in mice fed with GlcNAc, glucose or water (Fig. 2c).
Exploiting the fact that gut-evolved strains exhibited increased fitness upon commensalism but decreased fitness upon blood-borne infection23, we propose that although GlcNAc exerts inhibitory effect on commensal fitness, it may help retain the virulence potential of C. albicans. Recovered cells from all three independent evolution lines (Line 1–3) under each evolved condition were mixed as 1:1:1 ratio for the subsequent systemic infection assay. As expected, wild-type cells that recovered from murine gut enriched in GlcNAc exhibited significantly more virulent phenotype than that recovered from glucose (Fig. 2d). Although we could not detect a statistical significant difference in virulence between strains recovered from GlcNAc and water, mice infected with the former strain died observable faster than that infected with the latter one (Fig. 2d). ngs1 mutant recovered from glucose showed a similar level of virulence to that recovered from water (Fig. 2e). However, GlcNAc can still enhance the pathogenicity of ngs1 mutant during gut evolution (Fig. 2e), suggesting that GlcNAc sensing is involved in the inhibitory effect of GlcNAc on commensalism but not necessarily on the retention of virulence traits.
To confirm the critical role of GlcNAc on the regulation of commensal-pathogenic equilibrium, an additional independent evolution experiment was performed. Consistent with the previous results (Fig. 2b), all three clonal isolates recovered after 4 weeks evolution in the gut enriched in GlcNAc were strongly outcompeted by the clonal isolates that evolved in glucose or water in the mouse GI colonization model (Supplementary Fig. 2a). As expected, clonal isolates recovered from mice fed with water or glucose exhibited hypercompetitive phenotypes over the original WT strain SN250 (Supplementary Fig. 2b). By contrast, the fitness advantage was lost when cells were evolved in the gut enriched in GlcNAc (Supplementary Fig. 2b). We also observed a significant loss of virulence in cells recovered from mice fed with water or glucose (Supplementary Fig. 2c). However, cells evolved in the gut enriched in GlcNAc displayed only a slight decrease in virulence compared to that of SN250 (Supplementary Fig. 2c), implying that the ability to cause disease was mostly retained by GlcNAc during gut colonization. Altogether, these results indicate that the evolutionary process of C. albicans during gut colonization can be reshaped by GlcNAc that attenuates commensal fitness advantage but retains virulence potential of gut-evolved cells.
GlcNAc retains the potentiality of gut-evolved cells to form hyphae
Hypha-associated transcription in C. albicans inhibits commensalism but is crucial for its virulence5,7. This antagonistic regulation may contribute to the balance between commensal and pathogenic infection achieved by GlcNAc, as GlcNAc is a powerful inducer for hyphal morphogenesis. In agreement with a previous report23, C. albicans WT cells almost lost their ability to respond to hyphal-inducing stimuli after in vivo evolution (Fig. 3a). However, cells that serially passage through GI tract of mice fed with GlcNAc, but not glucose or water, were able to form hyphae in spider plates, although the ratio of wrinkled colonies was less than cells evolved under in vitro conditions (Fig. 3a). To our surprise, ngs1 mutant cells after 4 weeks evolution in the gut enriched in GlcNAc retained the ability to form hyphae comparable to that evolved under in vitro conditions (Fig. 3b), although Ngs1 was shown essential for hyphal development in response to GlcNAc in vitro16. This may provide an explanation why ngs1 mutant recovered from GlcNAc is much more virulent than that recovered from water or glucose (Fig. 2e). We next examined the expression of hypha-associated genes including SAP6 and HYR1, both of which are involved in commensal fitness7, in gut-evolved cells. As expected, a dramatic increase in expression of SAP6 and HYR1 was detected in WT cells recovered from murine gut enriched in GlcNAc than that in glucose or water during gut colonization (Fig. 3c). Despite retaining a normal filamentation pattern in vitro (Fig. 3b), we could not detect any increase in the expression of SAP6 or HYR1 in ngs1 mutant cells evolved in GlcNAc compared to that evolved in control water when colonized the gut (Fig. 3c). These results reinforce the opinion that cell morphology per se does not determine commensal fitness, but rather the hypha-associated transcription plays a critical role on it7.
In search of the genetic basis underlying GlcNAc-mediated retention of virulence of gut-evolved cells, one clonal isolate of WT strain was randomly picked from each independent evolution line (Line 1–3) in GlcNAc or control water for whole-genome sequencing. A total of 24 verified open-reading frames were found to contain ≥ 1 amino acid variation between gut-evolved strains adapted in GlcNAc and control water (Fig. 3d, Supplementary Data 1). On the basis of Gene Ontology (GO) enrichment analysis, 9 of these genes are related to filamentous growth (Fig. 3d). All three sequenced strains evolved in control water harbored loss-of-function mutations (premature stop codons or frame shifts) of FLO8 (Fig. 3d), which encodes an essential transcription factor for hyphal morphogenesis24. This is in agreement with a previous report23. Notably, no mutation in FLO8 was found in strains evolved in the gut enriched in GlcNAc compared to the reference strain SC5314 (Fig. 3d). Thus, we suggest that GlcNAc retains the ability of gut-evolved C. albicans to form hyphae through blocking mutations in FLO8, although variations in other genes may also contribute to GlcNAc-mediated retention of the capacity to form hyphae.
GlcNAc is critical for hyphal morphogenesis program of C. albicans in the gut
A recent study reported that ume6 null mutants undergo normal morphogenesis in the GI tract7, although they show filamentation defects under in vitro conditions25. It is well established that Ume6 functions as the terminal transcriptional activator of the hyphal gene regulatory network whose expression is highly induced during yeast-to-hyphae transition25,26. Interestingly, we found that GlcNAc, but not serum or neutral pH, could induce log-phase cells of ume6 mutant to form normal hyphae as wild-type cells (Fig. 4a). However, UME6 was necessary for the induction of hypha-associated proteins in response to GlcNAc, including Sap6 and Hyr1 (Fig. 4b). This is consistent with the notion that GlcNAc-induced expression of hypha-associated genes requires the presence of UME6 that restrains the capacity of C. albicans for gut colonization7. Because GlcNAc was shown to inhibit the growth of the ngs1 mutant at 37 °C in SD medium and the inhibitory effect could be removed by HXK1 deletion16, the ngs1hxk1 double mutant was used to examine the function of Ngs1 in hypha-associated UME6 expression. UME6 was dramatically upregulated upon GlcNAc induction in a Ngs1-dependent manner whereas Ngs1 is not required for UME6 induction in response to serum or neutral pH (Fig. 4c, d). Remarkably, a significant lower level in UME6 expression was observed in ngs1 mutant than that in wild type strain after three days of colonization (Fig. 4e) and overexpression of UME6 in ngs1 produced a strong loss-of-fitness phenotype (Supplementary Fig. 3), suggesting that decreased expression of UME6 contributes the enhanced fitness of ngs1. Given that Ngs1 is specifically required for hypha-specific transcription in response to GlcNAc16, the results, summarized in Fig. 3, clearly demonstrate that although the mammalian digestive tract is replete with signals that trigger yeast-to-hypha morphogenesis, GlcNAc plays a key role on hypha-associated program during gut colonization.
GlcNAc-induced transcriptome regarding colonization and virulence
To further investigate the function of GlcNAc in the balance between commensalism and virulence, we performed independent transcriptome sequencing (mRNA-Seq) analyses to profile ngs1 mutant and reference strain SN250. Animals were colonized with WT or ngs1 (n = 3 mice/strain) for 3 days, and RNA was recovered from large intestine. For comparison, both strains were also propagated in vitro in the presence of GlcNAc or glucose at 37 °C for 0.5 h (n = 3 cultures, Fig. 4a). For each sample, a minimum of 25 million mRNA-Seq reads mapped to the C. albicans genome. We detected expression of 6281C. albicans genes or roughly 98% of the predicted genome under at least one experimental condition (Supplementary Data 2).
To identify genes that require Ngs1 for normal expression in the gut, we compare the transcriptomes of commensally propagated WT and ngs1 strains. Using a 1.5-fold cutoff, there are 713 genes downregulated in ngs1 compared to WT in the gut (Fig. 5a). We next asked whether these genes are activated by GlcNAc in vitro. 489 genes upregulated in wild-type cells by 1.5-fold or more upon GlcNAc induction compared to that in glucose (Fig. 5a). We further aimed at discriminating genes activated by GlcNAc from those repressed by glucose. All of the genes that were identified as upregulated in maltose compared to glucose were therefore removed from this setting27. This filter criteria led to a list of 251 genes as GlcNAc-activated genes, among which 110 genes are regulated by Ngs1 (Fig. 5a). There was a significant overlap of this gene cluster with previous defined gene set that activated by Ngs1 in the gut (p = 1.05 × 10−26, hypergeometric test). We then focused on these 30 genes and subjected them to function analysis using Gene Ontology (GO). As shown in Fig. 5a (bottom), they were significantly enriched in genes for GlcNAc metabolic process (p = 0.0004), filamentous growth (p = 0.01), carbohydrate transport (p = 0.0002) and interspecies interaction (p = 4.38 × 10−5). Based on the information on Candida Genome Database (CGD), some genes are shown to implicate in C. albicans virulence, among which we picked out four representative genes including RBT1, SAP2, AAF1 and RFX2. Remarkably, they were dramatically induced in cells recovered from murine gut enriched in GlcNAc than that in glucose or water when they infected murine kidneys (Fig. 5b), supporting the capability of GlcNAc in virulence retention. We noticed that some of GlcNAc-responsive genes under in vitro conditions whose induction is independent of Ngs1 are clearly involved in pathogenicity of C. albicans, for example SOD528. As expected, we detected an increase in the expression of SOD5 in GlcNAc-evolved cells during invasive infection (Fig. 5c), indicating that GlcNAc retains C. albicans virulence potential also through Ngs1-independent pathways.
In addition to genes implicated in virulence, we noticed OFI1 whose expression was induced by GlcNAc in a Ngs1-dependent manner both in vitro and in murine gut (Fig. 5a). OFI1 was previously shown to promote phenotypic switching required for C. albicans mating29. The reduced expression of OFI1 in ngs1 mutant during gut colonization was confirmed by qRT-PCR (Fig. 5d). Given that the sexual switch is related to commensalism30, we asked whether decreased expression of OFI1 contributes to the enhanced commensal fitness of ngs1 mutant. To test this hypothesis, we profiled ofi1 null mutant in the GI colonization model. As shown in Fig. 5e, ofi1 mutant strongly outcompeted wild type in the mouse GI colonization model. Because deletion of OFI1 has no effect on filaments formation at 37 °C (Supplementary Fig. 4), our data suggest that, in addition to hypha-associated transcriptome, other cellular program(s) might also contribute to the inhibitory effect of GlcNAc on commensal fitness.
Discussion
C. albicans is the most prominent fungus residing in the human gut31, but also remains a deadly pathogen and a leading cause of bloodstream infections worldwide1,32. In order to develop successful approaches against candidiasis, it is necessary to understand how the balance between commensalism and virulence is established in the context of the complex host environment. In this study, we demonstrate that GlcNAc, an abundant carbon source in the GI tract, enables C. albicans to balance between commensalism and virulence (Fig. 5f). It represents a major inducer for the expression of hypha-associated genes, as well as other transcription programs in the mammalian gut (Fig. 5f), which allows C. albicans commensalism evolved with retention of virulence traits. Our work provides new insights into how a host-associated factor regulates the lifestyle of a commensal-pathogenic fungus.
GlcNAc is thought to be the primary carbon source of C. albicans, as it is used by the fungus as a signal for nutrient availability11. The ability to utilize GlcNAc as energy source is important for some bacteria to persist in mammalian gut18. We demonstrate that this is also the case for C. albicans. Ngs1 is the master regulator of GlcNAc signaling. To our surprise, deleting NGS1, confers a fitness advantage over wild-type strain (Fig. 1f), although the ngs1 mutant is unable to catabolize GlcNAc16, indicating that GlcNAc signaling exerts inhibitory effect on commensalism, which is dominant over its beneficial influence as a carbon source to support commensal growth. As such, Ngs1 functions as an inhibitor of commensalism, although it is essential for GlcNAc catabolism. Through serial passage in the GI tract of antibiotic-treated mice, C. albicans adapted to be hyper-fit as a gut commensal but decreased fitness upon blood-borne infection. These gut-evolved variants display defects in hyphae formation23. Using a similar experimental evolution approach, we showed that addition of GlcNAc in the gut could reshape this evolution process, in which the fitness advantage of gut-evolved strains was attenuated, but the virulence traits, such as the ability to form hyphae, were retained by blocking mutations in FLO8 (Figs. 2 and 3d). This indicates that although GlcNAc is disadvantageous for commensalism, it represents an evolutionary pressure to maintain key pathogenic attributes of C. albicans such that this commensal can cause diseases if host or environmental factors are permissive.
It is well documented that C. albicans morphogenesis program is central to the balance between gut commensalism and invasive infection. Witchley et al., reported that hyphal formation was observed throughout the gut, with greater abundance of hyphae over yeast cells in distal intestinal regions7. Although mammalian GI tract is replete with hypha-inducing signals, several lines of evidence presented in this study and literature suggest that GlcNAc serves as a major inducer for hyphal transcriptional program in C. albicans during gut colonization, thus dictating commensal-pathogenic properties of this fungus. First, GlcNAc, but not serum or neutral pH, could induce log phase cells of ume6 mutant to form normal hyphae (Fig. 4a), indicating that GlcNAc should be a host-associated signal that accounts for the in vitro-in vivo discrepancy observed in the filamentation potential of ume6 mutant. Second, despite normal filamentation observed in ume6 mutant in GlcNAc, GlcNAc failed to induce the expression of some hypha-associated proteins in this strain, including SAP6 and HYR1, both of which limit commensal fitness (Fig. 4b). This might lead to hyper-fit phenotype of ume6 mutant. Third, Brg1, a key regulator in GlcNAc-induced filamentation of log phase cells33, is also critical for hyphal morphogenesis in the gut7. Fourth and most strikingly, deletion of NGS1 results in a reduced UME6 expression when C. albicans colonizes the gut (Fig. 4e). This finding underscores the exclusive role of GlcNAc on the regulation of hypha-associated transcription during gut colonization as Ngs1 is specifically required for morphological program in response to GlcNAc16.
As a natural inhabitant of the human GI tract, C. albicans lives and coevolves in this complex niche. Why GlcNAc stands out from numerous known factors that trigger yeast-to-hypha morphogenesis in the gut? This could be attributed to its exceptional ability to induce hyphal formation under conditions without inoculation16,33. While many environmental cues favor hyphal growth when saturated cells are diluted into fresh medium at 37 °C, only GlcNAc, serum and neutral pH were identified to date to trigger hyphal development in log phase cells33,34. Given that serum is usually absent from mammalian GI tract where pH is fluctuated, GlcNAc, an abundant sugar in this niche, should be a suitable gut signaling molecule to control hypha-associated program in C. albicans during colonization. In addition to morphological program, other factors regulated by Ngs1, such as Ofi1, might also contribute to attenuated fitness induced by GlcNAc. It was recently reported that C. albicans specifically modulates human Th17 responses, leading to heterologous immunity and protecting against other invading pathogens35,36,37. Commensal Th17 immunity primed by C. albicans is regulated via oscillating UME6 expression38 and relies on the peptide toxin Candidalysin35,39. Given the fact that GlcNAc is a major inducer of hypha-associated transcription in the gut, we suggest that GlcNAc may represent a major evolutionary driving force for C. albicans to trigger systemic Th17 responses. Another more recent study revealed that a subset of immune cells detects C. albicans in the GI tract and leads to production of antifungal immunoglobulin G (IgG)40. GlcNAc-mediated expression of virulence traits may also contribute to this process. It will be interesting to test directly whether GlcNAc is important for this pathobiont to build up immunity against other pathogens.
Methods
Ethics statement
All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at Wuhan University and performed as outlined in the guide for the care and use of laboratory animals issued by the Ministry of Science and Technology of the People’s Republic of China.
Media and growth conditions
C. albicans strains were routinely grown at 30 °C in YPD (2% Bacto peptone, 2% glucose, 1% yeast extract). Transformants were selected on SC medium (0.17% Difco yeast nitrogen base w/o ammonium sulfate, 0.5% ammonium sulfate and auxotrophic supplements) with 2% glucose or on YPD plate supplemented with 200 µg/ml nourseothricin.
Spider medium (1% mannitol, 1% nutrient broth, 0.2% K2HPO4) with 2% agar was used for colony morphology assay at 37 °C. Hyphal induction in liquid medium was conducted as described previously16. Briefly, C. albicans cells grown overnight at 30 °C in liquid YPD were washed three times with PBS, resuspended in an equal volume of PBS, and diluted 1:100 into liquid SC medium containing 50 mM galactose. After 4 h of incubation at 30 °C, hyphal growth was induced by a shift in temperature to 37 °C in combination with 50 mM GlcNAc. In addition to GlcNAc, 10% Serum and neutral pH were used for morphology assay in this study as well. For neutral pH condition, cells were pelleted and resuspended in SC galactose medium buffered to pH 7 with 15 mM HEPES buffer (pH 7). Cell morphology was detected using differential interference contrast (DIC) optics at 3.5 h after transferring to 37 °C.
Plasmid and strain construction
The C. albicans strains used in this study are listed in Supplementary Table 1. Primers are listed in Supplementary Data 3. SC5314 genomic DNA was used as the template for all PCR amplifications of C. albicans genes.
The hxk1 nag1 dac1 triple mutant strain was constructed by two-step homologous recombination in BWP1741, and two copies of the genes were replaced by HIS1 and ARG4, respectively. HIS1 and ARG4 fragments are amplified from pGEM-HIS1 and pRS-ARG4ΔSpeI by primers 1 and 2. All deletions were confirmed by PCR.
Deletion of GIG1 in C. albicans was conducted using SAT1-flipping strategy42. Upstream (primers 9 and 10) and downstream (primers 11 and 12) sequences of GIG1 were cloned as ApaI-XhoI and NotI-SacII fragments, respectively, on both sides of the SAT1 flipper cassette to obtain the plasmid pSFS2-GIG1. To disrupt the endogenous copies of GIG1 in wild-type cells, pSFS2-GIG1 was linearized using KpnI and SacII, which was followed by two sequential rounds of transformation, selection, and recycling of the SAT1 marker. All deletions were confirmed by PCR.
WOR1 deletion was performed using CRISPR-Cas9 strategy as follows. The single guide RNA (sgRNA) (primers 3 and 4) was annealed to insert into the pV1093 vector43. The resulting plasmid was linearized by digestion with KpnI and SacI and transformed into WT or the ngs1 mutant with the repair template (primers 5 and 6). The mutants were verified by sequencing.
The pBES116-SAT1 plasmid was constructed by amplifying the SAT1 cassette (primers 7 and 8) from pSFS2 plasmid42. The PCR product was inserted into the NdeI-PstI site of pBES116 to create pBES116-SAT1 plasmid for strain construction in commensal competition experiments.
The pBES116-TDH3p-UME6 plasmid was constructed by amplifying UME6 coding region with primers 13 and 14. The resulting PCR product was inserted into pBES116-TDH3p plasmid33.
Commensal competition experiments in mouse
All animals were singly or doubly housed depending on experiment and provided autoclaved distilled water and autoclaved mouse chow. 6–8-week-old female BALB/c mice (purchased from Beijing Vital River Laboratory Animal Technology Company) were treated with antibiotics water (streptomycin, 2 mg/ml; penicillin, 0.97 mg/ml) for 3 days and then inoculated with a 1:1 mixture of a nourseothricin-resistant strain and an unmarked strain at 5 × 108 cells/ml by oral gavage as previously reported19. The antibiotics water was used throughout the commensal competition experiment. Colonization was tested over time by collecting fresh fecal pellets and plating homogenates on YPD plates containing streptomycin (100 µg/ml) and ampicillin (50 µg/ml) supplemented with or without 200 μg/ml nourseothricin. The competitive index (CI) of the competition experiment has been shown as the proportion of the indicated strain to the total. Mice were housed in a temperature-constant animal room (22 °C) with reversed dark/light cycle (7:00 a.m. on and 7:00 p.m. off) and 40–70% humidity.
Murine model of systemic infection
18–21 g male ICR mice were inoculated with 2.5 × 105 C. albicans cells by tail vein injection. Mice were monitored daily for overall health condition. The survival curve was calculated using GraphPad Prism. To determine the expression of virulence factors in C. albicans during systemic infection, 6–8-week-old BABL/c male mice were inoculated with 2 × 106 C. albicans cells by tail vein injection and infected kidneys were taken at the third day after injection for RNA extraction. Mice were housed in a temperature-constant animal room (22 °C) with reversed dark/light cycle (7:00 a.m. on and 7:00 p.m. off) and 40–70% humidity.
In vivo gastrointestinal evolution
The evolution experiment was performed in 6–8-week-old female BALB/c mice in the presence of antibiotics as described previously with modifications23. Mice were first colonized with 108 CFUs C. albicans cells. To minimize microbial transfer among cage mates, only one animal was housed per cage. After 7 days, a new set of naïve mice, pre-treated with antibiotics, was cohoused with the previous passage for 3 days. This treatment results in the successful colonization of C. albicans cells in the new set of mice. After 7 days, the procedure was repeated using another set of naïve mice as the recipients and serial passaging was performed weekly for 4 passages. At the end, animals were euthanized, and the content in large intestine was collected. Homogenates were grown on Sabouraud agar plates containing streptomycin (100 µg/ml) and ampicillin (50 µg/ml) for 24 h. All colonies were washed by PBS for subsequent experiments.
RNA sequencing and analysis
6–8-week-old female BALB/c mice were colonized with a single C. albicans strain (WT SN250 or ngs1 mutant). Three animals were colonized with each strain for 3 days and housed individually. Animals were euthanized, and the content in large intestine was flash frozen in liquid nitrogen and stored in −80 °C. For in vitro assays, C. albicans cells were grown in YPD medium to log phase at 30 °C, washed with PBS for three times, and then resuspended in YEP medium supplemented with 50 mM glucose or GlcNAc. Samples were collected after incubation at 37 °C for 0.5 h for RNA-seq analysis. Library preparation and sequencing of RNA was performed at Novogene (Beijing, China). A sequencing library was constructed by using a NEBNext Ultra RNA library prep kit for Illumina (New England BioLabs, USA). The RNA-Seq library was assessed by the Agilent Bioanalyzer 2100 system and quantified by qRT-PCR before sequencing on the Illumina NovaSeq platform. Clean reads were mapped to the C. albicans reference genome (SC5314_A21), and mapped reads were counted. Differentially expressed genes were defined by fold change ≥1.5 and a P value of <0.05 found by DESeq2 (1.34.0 in Rstudio). GO term process analysis was performed on the Candida Genome Database (http://www.candidagenome.org/cgi-bin/GO/goTermFinder) and viewed by ggplot2 (3.4.1).
RNA extraction and quantitative PCR expression analysis
Total RNA from C. albicans cells incubated under the in vitro conditions was purified using the RNAprep pure Tissue Kit and DNase-treated at room temperature for 15 min using the RNase-free DNase Set (Tiangen). Total RNA in the contents from the large intestines of mice was extracted using the Fecal RNA Extraction Kit (Biotech). Additionally, total RNA in the infected kidney of mouse was extracted using RNAiso Plus (TaKaRa). cDNA was synthesized using the MaximaTM H Minus cDNA Synthesis Master Mix with dsDNase (Thermo), and qPCR was done using the iQ SYBR Green Supermix (Bio-Rad). The primers for qRT-PCR were listed in Supplementary Data 3. The signals obtained from CDC28 mRNA were used for normalization. All data showed the average of three independent qRT-PCR experiments with error bars representing the SEM.
Whole-genome sequencing of C. albicans strains
Genomic DNA was extracted using plant genome DNA extraction kit (Sangon, Shanghai, China). The library preparation and next generation sequence was performed by Sangon Biotech (Shanghai) Co., Ltd. 500 ng quantified DNA was randomly fragmented by Covaris (Woburn, USA). Whole-genome sequencing libraries were prepared using Illumina Hieff NGS MaxUp II DNA Library Prep Kit (YEASEN, Shanghai, China). The library concentration and size was confirmed by Qubit 4.0 (Thermo, Waltham, USA) and 2% agarose gel electrophoresis respectively. Then the libraries were pooled and loaded on Novaseq 6000 (Illumina, San Diego, USA)/DNBseq-T7 (BGI, Shenzhen, China) to generate indexed paired-end reads of 2 × 150 bp.
Raw reads containing adaptor sequences and those with ambiguous or low-quality bases at the beginning or end were trimmed using Fastp. The qualified reads from each sample were aligned to the assembled C. albicans SC5314 reference genome (http://www.candidagenome.org/download/sequence/C_albicans_SC5314/Assembly21/current/) using BWA (0.7.17) with default parameters. Duplicated reads were removed and coverage values were calculated using SAMTOOLS. Primary variation calling was conducted using the Genome Analysis ToolKit (GATK, v4.1.2). The filtering of low-quality variants using the criteria “QD <2.0||MQ <40.0||FS> 60.0 ||| ReadPosRankSum <−8.0 || MQRankSum <−12.5||SOR> 3.0” generated the final variant set. The bam file produced from the mapping procedure was analyzed for structural variations (SVs) detection by DELLY (0.8.1) with default parameters. Copy number variations (CNVs) were detected with CALL in CNVnator (0.4). Functional annotation of all the genetic variants was completed by snpEff (4.3t). Comparing the different non-synonymous variations of control group with that of GlcNAc group, genes including specific variations occurring in either group were presented. GO term process analysis of the non-synonymous effect-coding genes was performed on the Candida Genome Database and p-values < 0.05 was considered as significantly enriched.
Statistical analysis
All experiments were performed with at least three biological repeats except indicated in the figure legends, and no statistical method was used to predetermine sample sizes. Analyses were conducted using Graphpad Prism 9.0 software. Results are expressed as the mean ± SEM as indicated, and analyzed using Student’s t test. P values of less than 0.05 were considered statistically significant.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
RNA-Seq data and genome sequencing data that support the findings of this study have been deposited in the Genome Sequence Archive (GSA) under the accession code CRA010506 and CRA010507 respectively. Reference genomes and genome annotations were obtained from Candida Genome Database. The generated strains in this study are available from the corresponding author upon request. Source data are provided with this paper.
References
Brown, G. D. et al. Hidden killers: human fungal infections. Sci. Transl. Med. 4 https://doi.org/10.1126/scitranslmed.3004404 (2012).
Pfaller, M. A. & Diekema, D. J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20, 133–163 (2007).
Bongomin, F., Gago, S., Oladele, R. O. & Denning, D. W. Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi 3, https://doi.org/10.3390/jof3040057 (2017).
Noble, S. M., Gianetti, B. A. & Witchley, J. N. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat. Rev. Microbiol. 15, 96–108 (2017).
Lo, H. J. et al. Nonfilamentous C-albicans mutants are avirulent. Cell 90, 939–949 (1997).
Lu, Y., Su, C., Solis, N. V., Filler, S. G. & Liu, H. P. Synergistic regulation of hyphal elongation by hypoxia, CO2, and nutrient conditions controls the virulence of Candida albicans. Cell Host Microbe 14, 499–509 (2013).
Witchley, J. N. et al. Candida albicans morphogenesis programs control the balance between gut commensalism and invasive infection. Cell Host Microbe 25, 432–443.e6 (2019).
Liang, S. H. et al. Hemizygosity enables a mutational transition governing fungal virulence and commensalism. Cell Host Microbe 25, 418–431.e6 (2019).
Konopka, J. B. N-acetylglucosamine (GlcNAc) functions in cell signaling. Scientifica 2012, https://doi.org/10.6064/2012/489208 (2012).
Pande, K., Chen, C. B. & Noble, S. M. Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism. Nat. Genet. 45, 1088–1091 (2013).
Du, H. et al. N-Acetylglucosamine-induced cell death in Candida albicans and its implications for adaptive mechanisms of nutrient sensing in yeasts. Mbio 6 https://doi.org/10.1128/mBio.01376-15 (2015).
Sullivan, P. A. & Shepherd, M. G. Gratuitous induction by N-acetylmannosamine of germ tube formation and enzymes for N-acetylglucosamine utilization in Candida-Albicans. J. Bacteriol. 151, 1118–1122 (1982).
Huang, G. H. et al. N-Acetylglucosamine induces white to opaque switching, a mating prerequisite in Candida albicans. Plos Pathog. 6 https://doi.org/10.1371/journal.ppat.1000806 (2010).
Gow, N. A. R., Brown, A. J. P. & Odds, F. C. Fungal morphogenesis and host invasion. Curr. Opin. Microbiol. 5, 366–371 (2002).
Kumamoto, C. A. & Vinces, M. D. Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol. 7, 1546–1554 (2005).
Su, C., Lu, Y. & Liu, H. P. N-acetylglucosamine sensing by a GCN5-related N-acetyltransferase induces transcription via chromatin histone acetylation in fungi. Nat. Commun. 7, https://doi.org/10.1038/ncomms12916 (2016).
Ishijima, S. A. et al. N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis. Med. Mycol. 50, 252–258 (2012).
Chang, D. E. et al. Carbon nutrition of Escherichia coli in the mouse intestine. Proc. Natl Acad. Sci. USA 101, 7427–7432 (2004).
Pierce, J. V. & Kumamoto, C. A. Variation in Candida albicans EFG1 expression enables host-dependent changes in colonizing fungal populations. Mbio 3 https://doi.org/10.1128/mBio.00117-12 (2012).
Gunasekera, A. et al. Identification of GIG1, a GlcNAc-induced gene in candida albicans needed for normal sensitivity to the chitin synthase inhibitor nikkomycin Z. Eukaryot. Cell 9, 1476–1483 (2010).
Naseem, S., Min, K., Spitzer, D., Gardin, J. & Konopka, J. B. Regulation of hyphal growth and N-acetylglucosamine catabolism by two transcription factors in Candida albicans. Genetics 206, 299–314 (2017).
Ruhela, D. et al. In vivo role of Candida albicans beta-hexosaminidase (HEX1) in carbon scavenging. Microbiologyopen 4, 730–742 (2015).
Tso, G. H. W. et al. Experimental evolution of a fungal pathogen into a gut symbiont. Science 362, 589–595 (2018).
Cao, F. et al. The Flo8 transcription factor is essential for hyphal development and virulence in Candida albicans. Mol. Biol. Cell 17, 295–307 (2006).
Banerjee, M. et al. UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol. Biol. Cell 19, 1354–1365 (2008).
Carlisle, P. L. et al. Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proc. Natl Acad. Sci. USA 106, 599–604 (2009).
Cottier, F. et al. The transcriptional response of Candida albicans to weak organic acids, carbon source, and MIG1 inactivation unveils a role for HGT16 in mediating the fungistatic effect of acetic acid. G3 Genes Genom. Genet 7, 3597–3604 (2017).
Martchenko, M., Alarco, A. M., Harcus, D. & Whiteway, M. Superoxide dismutases in Candida albicans: transcriptional regulation and functional characterization of the hyphal-induced SOD5 gene. Mol. Biol. Cell 15, 456–467 (2004).
Du, H., Li, X. L., Huang, G. H., Kang, Y. Q. & Zhu, L. Q. The zinc-finger transcription factor, Ofi1, regulates white-opaque switching and filamentation in the yeast Candida albicans. Acta Biochim. Biophys. Sin. 47, 335–341 (2015).
Witchley, J. N., Basso, P., Brimacombe, C. A., Abon, N. V. & Noble, S. M. Recording of DNA-binding events reveals the importance of a repurposed Candida albicans regulatory network for gut commensalism. Cell Host Microbe 29, 1002–1013.e9 (2021).
Li, X. V., Leonardi, I. & Iliev, I. D. Gut mycobiota in immunity and inflammatory disease. Immunity 50, 1365–1379 (2019).
Zhai, B. et al. High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat. Med. 26, 59–64 (2020).
Su, C., Yu, J., Sun, Q. Q., Liu, Q. & Lu, Y. Hyphal induction under the condition without inoculation in Candida albicans is triggered by Brg1-mediated removal of NRG1 inhibition. Mol. Microbiol. 108, 410–423 (2018).
Enjalbert, B. & Whiteway, M. Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth. Eukaryot. Cell 4, 1203–1210 (2005).
Bacher, P. et al. Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans. Cell 176, 1340–1355.e15 (2019).
Shao, T. Y. et al. Commensal Candida albicans positively calibrates systemic Th17 immunological responses. Cell Host Microbe 25, 404–417.e6 (2019).
Atarashi, K. et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367–380 (2015).
Shao, T. Y. et al. Candida albicans oscillating UME6 expression during intestinal colonization primes systemic Th17 protective immunity. Cell Rep. 39 https://doi.org/10.1016/j.celrep.2022.110837 (2022).
Moyes, D. L. et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532, 64–68 (2016).
Doron, I. et al. Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies. Cell 184, 1017–1031.e14 (2021).
Wilson, R. B., Davis, D. & Mitchell, A. P. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J. Bacteriol. 181, 1868–1874 (1999).
Reuss, O., Vik, A., Kolter, R. & Morschhauser, J. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341, 119–127 (2004).
Vyas, V. K., Barrasa, M. I. & Fink, G. R. A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci. Adv. 1, e1500248 (2015).
Acknowledgements
We thank Dr. S. Noble and Fungal Genetics Stock Center for kindly providing Candida strain. This work was supported by grants from National Natural Science Foundation of China (32070074 to Y.L., 32170089 and 81973370 to C.S.) and a grant from Natural Science Foundation of Hubei Province of China (2022CFB103 to C.S.).
Author information
Authors and Affiliations
Contributions
Y.L., C.S. and D.Y. designed the experiments. D.Y., M.Z., B.D. and C.S. performed the experiments. D.Y., M.Z., Y.L. and C.S. performed data analyses. Y.L., C.S. and D.Y. wrote the paper with input from the co-authors.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yang, D., Zhang, M., Su, C. et al. Candida albicans exploits N-acetylglucosamine as a gut signal to establish the balance between commensalism and pathogenesis. Nat Commun 14, 3796 (2023). https://doi.org/10.1038/s41467-023-39284-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-023-39284-w
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.